nach oben

Erschienen in:

01.03.2013 | Original Research

Evaluation of a Prospective Surgical Strategy of Extended Resection to Achieve R0 Status in Gall Bladder Cancer

verfasst von: Biju Pottakkat, Abhimanyu Kapoor, Anand Prakash, Rajneesh Kumar Singh, Anu Behari, Ashok Kumar, Vinay K. Kapoor, Rajan Saxena

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Radical resection to achieve R0 status remains the only potential curative option in patients with gall bladder cancer (GBC). This study was aimed to evaluate the efficacy of an extended criterion of radical resection to achieve R0 status in GBC.

Methods

A triple-phase CT with 3D reconstruction was done in all patients. A standard resectability criterion was followed in all patients. A minimum of liver segment 4B + 5 resection and radical lymphadenectomy including the para-aortic areas were undertaken in all patients. Adjacent organectomy was added as required.

Results

Between November 2008 and April 2011, 59 patients with GBC underwent operation and 40 (resectability, 68 %) underwent resection. The resectional procedures performed were segmentectomy 4B + 5 in 31 (78 %), median sectorectomy in 2 (5 %), extended right hepatectomy in 3 (8 %), and hepatopancreaticoduodenectomy in 4 (10 %) patients. Postoperative complications occurred in 24 (60 %) patients. Two patients died postoperatively. A total of 829 lymph nodes were harvested and the median lymph node count was 18 (4–77). Twenty-three (58 %) patients had lymph node metastases. Twenty-eight of 40 (70 %) had disease limited till N1 nodes. Metastases up to N2 lymph nodes were seen in 12 (30 %). American Joint Committee on Cancer seventh edition stages were I—2 (5 %) patients, II—5 (13 %), III—19 (48 %), and IV—14 (35 %). R0 resection was achieved in 33 (83 %) patients. Four patients had recurrence and one died of recurrence. All other patients are alive till the last follow-up.

Conclusions

Assessment with triple-phase CT with 3D reconstruction can produce high resectability rate in GBC. Extended criterion of radical resection results in R0 status in more than 80 % of patients with GBC.

Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010;15(2):168–81. Epub 2010 Feb 10. Review.PubMedCrossRef

Pilgrim C, Usatoff V, Evans PM. A review of the surgical strategies for the management of gallbladder carcinoma based on T stage and growth type of the tumour. Eur J Surg Oncol. 2009;35(9):903–7. Epub 2009 Mar 4.PubMedCrossRef

Balachandran P, Agarwal S, Krishnani N, Pandey CM, Kumar A, Sikora SS, Saxena R, Kapoor VK. Predictors of long-term survival in patients with gallbladder cancer. J Gastrointest Surg. 2006;10(6):848–54.PubMedCrossRef

Ito M, Mishima Y, Sato T. An anatomical study of the lymphatic drainage of the gallbladder. Surg Radiol Anat. 1991;13(2):89–104.PubMedCrossRef

American Joint Committee on Cancer. Gallbladder. In: AJCC cancer staging manual. 7th ed. New York: Springer; 2010 211–214.

Liang JW, Dong SX, Zhou ZX, Tian YT, Zhao DB, Wang CF, Zhao P. Surgical management for carcinoma of the gallbladder: a single-institution experience in 25 years. Chin Med J (Engl). 2008;121(19):1900–5.

Chan SY, Poon RT, Lo CM, Ng KK, Fan ST. Management of carcinoma of the gallbladder: a single-institution experience in 16 years. J Surg Oncol. 2008;97(2):156–64.PubMedCrossRef

Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K, Herman J, Schulick RD, Choti MA, Pawlik TM. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg. 2010;14(10):1578–91.PubMedCrossRef

Butte JM, Matsuo K, Gönen M, D'Angelica MI, Waugh E, Allen PJ, Fong Y, DeMatteo RP, Blumgart L, Endo I, De La Fuente H, Jarnagin WR. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212(1):50–61.PubMedCrossRef

10.

Chakravarty KD, Yeh CN, Jan YY, Chen MF. Factors influencing long-term survival in patients with T3 gallbladder adenocarcinoma. Digestion. 2009;79(3):151–7. Epub 2009 Mar 30.PubMedCrossRef

11.

Kai M, Chijiiwa K, Ohuchida J, Nagano M, Hiyoshi M, Kondo K. A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma. J Gastrointest Surg. 2007;11(8):1025–32.PubMedCrossRef

12.

Kapoor VK. Incidental gall bladder cancer. Am J Gastroenterol. 2001;96(3):627–9.PubMedCrossRef

13.

Araida T, Higuchi R, Hamano M, Kodera Y, Takeshita N, Ota T, Yoshikawa T, Yamamoto M, Takasaki K. Hepatic resection in 485 R0 pT2 and pT3 cases of advanced carcinoma of the gallbladder: results of a Japanese Society of Biliary Surgery survey—a multicenter study. J Hepatobiliary Pancreat Surg. 2009;16(2):204–15. Epub 2009 Feb 14.PubMedCrossRef

14.

Goetze TO, Paolucci V. Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry. Surg Endosc. 2010;24(9):2156–64. Epub 2010 Feb 23.PubMedCrossRef

15.

Morine Y, Shimada M, Imura S, Fujii M, Ikemoto T, Soejima Y, Utsunomiya T, Kurita N, Miyake H, Tashiro S. Surgical strategy for advanced gallbladder carcinoma according to invasive depth of the tumor. Hepatogastroenterology. 2008;55(88):1965–70.PubMed

16.

Kohya N, Miyazaki K. Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma. J Surg Oncol. 2008;97(6):498–502.PubMedCrossRef

17.

Terazawa T, Miyake H, Kurahashi M, Tashiro S. Direct lymphatic spreading route into the liver from the gallbladder: an animal experiment using pig. J Med Invest. 2004;51(3–4):210–7.PubMedCrossRef

18.

Wang JD, Liu YB, Quan ZW, Li SG, Wang XF, Shen J. Role of regional lymphadenectomy in different stage of gallbladder carcinoma. Hepatogastroenterology. 2009;56(91–92):593–6.PubMed

19.

Kokudo N, Makuuchi M, Natori T, Sakamoto Y, Yamamoto J, Seki M, Noie T, Sugawara Y, Imamura H, Asahara S, Ikari T. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg. 2003;138(7):741–50. discussion 750.PubMedCrossRef

20.

Kondo S, Nimura Y, Hayakawa N, Kamiya J, Nagino M, Uesaka K. Extensive surgery for carcinoma of the gallbladder. Br J Surg. 2002;89(2):179–84.PubMed

21.

Shimada H, Endo I, Fujii Y, Kamiya N, Masunari H, Kunihiro O, Tanaka K, Misuta K, Togo S. Appraisal of surgical resection of gallbladder cancer with special reference to lymph node dissection. Langenbecks Arch Surg. 2000;385(8):509–14.PubMedCrossRef

22.

Kondo S, Nimura Y, Hayakawa N, Kamiya J, Nagino M, Uesaka K. Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg. 2000;87(4):418–22.PubMedCrossRef

23.

Nishio H, Nagino M, Ebata T, Yokoyama Y, Igami T, Nimura Y. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepatobiliary Pancreat Surg. 2007;14(4):351–7. Epub 2007 Jul 30.PubMedCrossRef

24.

Chijiiwa K, Kai M, Nagano M, Hiyoshi M, Ohuchida J, Kondo K. Outcome of radical surgery for stage IV gallbladder carcinoma. J Hepatobiliary Pancreat Surg. 2007;14(4):345–50. Epub 2007 Jul 30.PubMedCrossRef

25.

Sasaki R, Itabashi H, Fujita T, Takeda Y, Hoshikawa K, Takahashi M, Funato O, Nitta H, Kanno S, Saito K. Significance of extensive surgery including resection of the pancreas head for the treatment of gallbladder cancer—from the perspective of mode of lymph node involvement and surgical outcome. World J Surg. 2006;30(1):36–42.PubMedCrossRef

26.

Shirai Y, Yoshida K, Tsukada K, Ohtani T, Muto T. Identification of the regional lymphatic system of the gallbladder by vital staining. Br J Surg. 1992;79(7):659–62.PubMedCrossRef

27.

Araida T, Higuchi R, Hamano M, Kodera Y, Takeshita N, Ota T, Yoshikawa T, Yamamoto M, Takasaki K. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study. Surg Today. 2009;39(9):770–9. Epub 2009 Sep 24.PubMedCrossRef

28.

Yagi H, Shimazu M, Kawachi S, Tanabe M, Aiura K, Wakabayashi G, Ueda M, Nakamura Y, Kitajima M. Retrospective analysis of outcome in 63 gallbladder carcinoma patients after radical resection. J Hepatobiliary Pancreat Surg. 2006;13(6):530–6. Epub 2006 Nov 30.PubMedCrossRef

29.

Araida T, Yoshikawa T, Azuma T, Ota T, Takasaki K, Hanyu F. Indications for pancreatoduodenectomy in patients undergoing lymphadenectomy for advanced gallbladder carcinoma. J Hepatobiliary Pancreat Surg. 2004;11(1):45–9.PubMedCrossRef

30.

Sasaki R, Takahashi M, Funato O, Nitta H, Murakami M, Kawamura H, Suto T, Kanno S, Saito K. Hepatopancreatoduodenectomy with wide lymph node dissection for locally advanced carcinoma of the gallbladder—long-term results. Hepatogastroenterology. 2002;49(46):912–5.PubMed

31.

Shimada H, Endo I, Sugita M, Masunari H, Fujii Y, Tanaka K, Misuta K, Sekido H, Togo S. Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder. World J Surg. 2003;27(10):1137–42. Epub 2003 Aug 21.PubMedCrossRef

32.

Agrawal S, Sonawane RN, Behari A, Kumar A, Sikora SS, Saxena R, Kapoor VK. Laparoscopic staging in gallbladder cancer. Dig Surg. 2005;22(6):440–5. Epub 2006 Feb 10.PubMedCrossRef

Titel: Evaluation of a Prospective Surgical Strategy of Extended Resection to Achieve R0 Status in Gall Bladder Cancer
verfasst von: Biju Pottakkat
Abhimanyu Kapoor
Anand Prakash
Rajneesh Kumar Singh
Anu Behari
Ashok Kumar
Vinay K. Kapoor
Rajan Saxena
Publikationsdatum: 01.03.2013
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe 1/2013
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-012-9432-z

Springer Medizin

Evaluation of a Prospective Surgical Strategy of Extended Resection to Achieve R0 Status in Gall Bladder Cancer